nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PLA2G4A—autistic disorder	0.746	1	CbGaD
Orlistat—LIPF—digestive system—autistic disorder	0.0102	0.11	CbGeAlD
Orlistat—DAGLA—forebrain—autistic disorder	0.00938	0.101	CbGeAlD
Orlistat—PNLIP—mouth—autistic disorder	0.00819	0.0884	CbGeAlD
Orlistat—DAGLA—head—autistic disorder	0.00537	0.0579	CbGeAlD
Orlistat—ABHD12—eye—autistic disorder	0.00521	0.0562	CbGeAlD
Orlistat—DAGLA—nervous system—autistic disorder	0.00509	0.0549	CbGeAlD
Orlistat—DAGLA—central nervous system—autistic disorder	0.0049	0.0529	CbGeAlD
Orlistat—DAGLA—cerebellum—autistic disorder	0.00479	0.0517	CbGeAlD
Orlistat—FASN—telencephalon—autistic disorder	0.00398	0.043	CbGeAlD
Orlistat—DAGLA—brain—autistic disorder	0.00389	0.042	CbGeAlD
Orlistat—DAGLB—cerebellum—autistic disorder	0.00371	0.0401	CbGeAlD
Orlistat—PNLIP—digestive system—autistic disorder	0.00362	0.0391	CbGeAlD
Orlistat—DAGLB—brain—autistic disorder	0.00302	0.0326	CbGeAlD
Orlistat—PNLIP—head—autistic disorder	0.00296	0.0319	CbGeAlD
Orlistat—ABHD16A—cerebellum—autistic disorder	0.00282	0.0304	CbGeAlD
Orlistat—ABHD12—cerebellum—autistic disorder	0.00264	0.0285	CbGeAlD
Orlistat—PLA2G7—brain—autistic disorder	0.00244	0.0263	CbGeAlD
Orlistat—FASN—cerebellum—autistic disorder	0.00221	0.0239	CbGeAlD
Orlistat—ABHD12—brain—autistic disorder	0.00214	0.0231	CbGeAlD
Orlistat—FASN—brain—autistic disorder	0.0018	0.0194	CbGeAlD
Orlistat—PLA2G4A—nervous system—autistic disorder	0.00113	0.0122	CbGeAlD
Orlistat—PLA2G4A—central nervous system—autistic disorder	0.00109	0.0117	CbGeAlD
Orlistat—PLA2G4A—brain—autistic disorder	0.000864	0.00933	CbGeAlD
Orlistat—CYP3A4—digestive system—autistic disorder	0.000482	0.0052	CbGeAlD
Orlistat—CYP3A4—nervous system—autistic disorder	0.000373	0.00403	CbGeAlD
Orlistat—CYP3A4—central nervous system—autistic disorder	0.000359	0.00388	CbGeAlD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	4.42e-05	0.000274	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—ADM—autistic disorder	4.39e-05	0.000272	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—GABBR1—autistic disorder	4.39e-05	0.000272	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IGF2—autistic disorder	4.37e-05	0.000271	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ITGB3—autistic disorder	4.37e-05	0.000271	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PRKCB—autistic disorder	4.32e-05	0.000268	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PRKCB—autistic disorder	4.32e-05	0.000268	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	4.31e-05	0.000267	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ADSL—autistic disorder	4.29e-05	0.000266	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PDE4B—autistic disorder	4.28e-05	0.000265	CbGpPWpGaD
Orlistat—FASN—Metabolism—COMT—autistic disorder	4.27e-05	0.000264	CbGpPWpGaD
Orlistat—PNLIP—Disease—SERPINE1—autistic disorder	4.25e-05	0.000264	CbGpPWpGaD
Orlistat—FASN—Metabolism—GSTP1—autistic disorder	4.24e-05	0.000263	CbGpPWpGaD
Orlistat—FASN—Metabolism—MAOA—autistic disorder	4.24e-05	0.000263	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—XDH—autistic disorder	4.2e-05	0.000261	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—IL2—autistic disorder	4.19e-05	0.00026	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—OPRM1—autistic disorder	4.14e-05	0.000257	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—APC—autistic disorder	4.13e-05	0.000256	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—APC—autistic disorder	4.13e-05	0.000256	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PIK3CG—autistic disorder	4.13e-05	0.000256	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PIK3CG—autistic disorder	4.13e-05	0.000256	CbGpPWpGaD
Orlistat—FASN—Metabolism—CAT—autistic disorder	4.13e-05	0.000256	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—STX1A—autistic disorder	4.13e-05	0.000256	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NPAS2—autistic disorder	4.13e-05	0.000256	CbGpPWpGaD
Orlistat—FASN—Disease—MTHFR—autistic disorder	4.12e-05	0.000255	CbGpPWpGaD
Orlistat—FASN—Disease—HLA-A—autistic disorder	4.11e-05	0.000255	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PIK3CG—autistic disorder	4.09e-05	0.000254	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—EGF—autistic disorder	4.08e-05	0.000253	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—EGF—autistic disorder	4.08e-05	0.000253	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HTR2A—autistic disorder	4.08e-05	0.000253	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—HRAS—autistic disorder	4.05e-05	0.000251	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GABBR2—autistic disorder	4.02e-05	0.000249	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—TCN2—autistic disorder	3.99e-05	0.000247	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—POMC—autistic disorder	3.93e-05	0.000244	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—POMC—autistic disorder	3.93e-05	0.000244	CbGpPWpGaD
Orlistat—FASN—Disease—TSC2—autistic disorder	3.92e-05	0.000243	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—ITGB3—autistic disorder	3.91e-05	0.000243	CbGpPWpGaD
Orlistat—FASN—Metabolism—PLA2G4A—autistic disorder	3.9e-05	0.000242	CbGpPWpGaD
Orlistat—FASN—Metabolism—GSTM1—autistic disorder	3.9e-05	0.000242	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—POMC—autistic disorder	3.9e-05	0.000242	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TSC2—autistic disorder	3.88e-05	0.00024	CbGpPWpGaD
Orlistat—FASN—Disease—APOE—autistic disorder	3.83e-05	0.000238	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ADA—autistic disorder	3.8e-05	0.000236	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—LEP—autistic disorder	3.79e-05	0.000235	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—APOE—autistic disorder	3.79e-05	0.000235	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IGF1—autistic disorder	3.78e-05	0.000235	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IGF1—autistic disorder	3.78e-05	0.000235	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—MAPK1—autistic disorder	3.76e-05	0.000233	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—MAPK1—autistic disorder	3.76e-05	0.000233	CbGpPWpGaD
Orlistat—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	3.76e-05	0.000233	CbGpPWpGaD
Orlistat—FASN—Metabolism—GPX1—autistic disorder	3.74e-05	0.000232	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTGS2—autistic disorder	3.71e-05	0.00023	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—OXT—autistic disorder	3.68e-05	0.000228	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR1B—autistic disorder	3.68e-05	0.000228	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	3.6e-05	0.000223	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	3.6e-05	0.000223	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—SERPINE1—autistic disorder	3.59e-05	0.000223	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—SERPINE1—autistic disorder	3.59e-05	0.000223	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR1D—autistic disorder	3.59e-05	0.000222	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PRKCB—autistic disorder	3.58e-05	0.000222	CbGpPWpGaD
Orlistat—FASN—Disease—NOS2—autistic disorder	3.57e-05	0.000221	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—RORA—autistic disorder	3.47e-05	0.000215	CbGpPWpGaD
Orlistat—FASN—Disease—APC—autistic disorder	3.46e-05	0.000214	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PRLR—autistic disorder	3.45e-05	0.000214	CbGpPWpGaD
Orlistat—FASN—Metabolism—MTHFR—autistic disorder	3.45e-05	0.000214	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—APC—autistic disorder	3.42e-05	0.000212	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PIK3CG—autistic disorder	3.42e-05	0.000212	CbGpPWpGaD
Orlistat—FASN—Disease—EGF—autistic disorder	3.42e-05	0.000212	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DRD1—autistic disorder	3.42e-05	0.000212	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—EGF—autistic disorder	3.38e-05	0.00021	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GRM8—autistic disorder	3.33e-05	0.000207	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DRD3—autistic disorder	3.31e-05	0.000205	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—POMC—autistic disorder	3.26e-05	0.000202	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MAOB—autistic disorder	3.25e-05	0.000202	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL5—autistic disorder	3.24e-05	0.000201	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTEN—autistic disorder	3.24e-05	0.000201	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—WNT2—autistic disorder	3.23e-05	0.0002	CbGpPWpGaD
Orlistat—FASN—Metabolism—APOE—autistic disorder	3.21e-05	0.000199	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PRKCB—autistic disorder	3.2e-05	0.000199	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—autistic disorder	3.2e-05	0.000199	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CALCA—autistic disorder	3.2e-05	0.000198	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GHR—autistic disorder	3.18e-05	0.000197	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS2—autistic disorder	3.17e-05	0.000196	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IGF1—autistic disorder	3.13e-05	0.000194	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PDE4A—autistic disorder	3.13e-05	0.000194	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTGS2—autistic disorder	3.11e-05	0.000193	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—autistic disorder	3.09e-05	0.000192	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PIK3CG—autistic disorder	3.07e-05	0.00019	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—POMC—autistic disorder	3.05e-05	0.000189	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—EGF—autistic disorder	3.03e-05	0.000188	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—HRAS—autistic disorder	3.02e-05	0.000187	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HRAS—autistic disorder	3.02e-05	0.000187	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—TPH2—autistic disorder	3.02e-05	0.000187	CbGpPWpGaD
Orlistat—FASN—Disease—SERPINE1—autistic disorder	3.01e-05	0.000186	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SERPINE1—autistic disorder	2.98e-05	0.000185	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—DPYD—autistic disorder	2.97e-05	0.000184	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AVPR1A—autistic disorder	2.93e-05	0.000182	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL2—autistic disorder	2.91e-05	0.00018	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL2—autistic disorder	2.91e-05	0.00018	CbGpPWpGaD
Orlistat—FASN—Metabolism—PIK3CG—autistic disorder	2.9e-05	0.00018	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL6—autistic disorder	2.89e-05	0.000179	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL6—autistic disorder	2.89e-05	0.000179	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GRM5—autistic disorder	2.83e-05	0.000176	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—VIP—autistic disorder	2.83e-05	0.000176	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IGF1—autistic disorder	2.81e-05	0.000174	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.79e-05	0.000173	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CACNA1C—autistic disorder	2.76e-05	0.000171	CbGpPWpGaD
Orlistat—FASN—Metabolism—POMC—autistic disorder	2.76e-05	0.000171	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—OXTR—autistic disorder	2.74e-05	0.00017	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PTEN—autistic disorder	2.74e-05	0.00017	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PTEN—autistic disorder	2.74e-05	0.00017	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SCT—autistic disorder	2.72e-05	0.000168	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTEN—autistic disorder	2.71e-05	0.000168	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—CYP19A1—autistic disorder	2.7e-05	0.000167	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—ADRB2—autistic disorder	2.68e-05	0.000166	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—SERPINE1—autistic disorder	2.67e-05	0.000165	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—CYP19A1—autistic disorder	2.66e-05	0.000165	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.66e-05	0.000165	CbGpPWpGaD
Orlistat—PNLIP—Disease—MAPK1—autistic disorder	2.63e-05	0.000163	CbGpPWpGaD
Orlistat—FASN—Disease—PTGS2—autistic disorder	2.63e-05	0.000163	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GABBR1—autistic disorder	2.59e-05	0.000161	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADM—autistic disorder	2.59e-05	0.000161	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EIF4E—autistic disorder	2.55e-05	0.000158	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PDE4B—autistic disorder	2.53e-05	0.000157	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AVP—autistic disorder	2.52e-05	0.000156	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—DHFR—autistic disorder	2.51e-05	0.000156	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—COMT—autistic disorder	2.51e-05	0.000155	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GSTP1—autistic disorder	2.49e-05	0.000155	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—MAOA—autistic disorder	2.49e-05	0.000154	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	2.47e-05	0.000153	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	2.46e-05	0.000153	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—OPRM1—autistic disorder	2.45e-05	0.000152	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL2—autistic disorder	2.41e-05	0.000149	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GSTM1—autistic disorder	2.29e-05	0.000142	CbGpPWpGaD
Orlistat—FASN—Disease—PTEN—autistic disorder	2.29e-05	0.000142	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PTEN—autistic disorder	2.27e-05	0.000141	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	2.26e-05	0.00014	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GZMB—autistic disorder	2.24e-05	0.000139	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MAPK1—autistic disorder	2.22e-05	0.000138	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MAPK1—autistic disorder	2.22e-05	0.000138	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGS2—autistic disorder	2.2e-05	0.000136	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR1B—autistic disorder	2.17e-05	0.000135	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—OXT—autistic disorder	2.17e-05	0.000135	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IL2—autistic disorder	2.16e-05	0.000134	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ACADSB—autistic disorder	2.14e-05	0.000133	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—INPP1—autistic disorder	2.14e-05	0.000133	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.12e-05	0.000131	CbGpPWpGaD
Orlistat—PNLIP—Disease—HRAS—autistic disorder	2.11e-05	0.000131	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR2A—autistic disorder	2.1e-05	0.00013	CbGpPWpGaD
Orlistat—PNLIP—Disease—IL6—autistic disorder	2.02e-05	0.000125	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DRD1—autistic disorder	2.02e-05	0.000125	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TSC1—autistic disorder	2.02e-05	0.000125	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CYP19A1—autistic disorder	1.97e-05	0.000122	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NTRK2—autistic disorder	1.96e-05	0.000122	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DRD3—autistic disorder	1.96e-05	0.000121	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTEN—autistic disorder	1.92e-05	0.000119	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL5—autistic disorder	1.91e-05	0.000119	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—BTD—autistic disorder	1.91e-05	0.000119	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CALCA—autistic disorder	1.89e-05	0.000117	CbGpPWpGaD
Orlistat—FASN—Disease—MAPK1—autistic disorder	1.86e-05	0.000115	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.85e-05	0.000115	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MAPK1—autistic disorder	1.84e-05	0.000114	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PRKCB—autistic disorder	1.84e-05	0.000114	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—COMT—autistic disorder	1.83e-05	0.000113	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTP1—autistic disorder	1.82e-05	0.000113	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MAOA—autistic disorder	1.82e-05	0.000113	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HRAS—autistic disorder	1.79e-05	0.000111	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HRAS—autistic disorder	1.79e-05	0.000111	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CAT—autistic disorder	1.77e-05	0.00011	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PIK3CG—autistic disorder	1.76e-05	0.000109	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL6—autistic disorder	1.71e-05	0.000106	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL6—autistic disorder	1.71e-05	0.000106	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—POMC—autistic disorder	1.67e-05	0.000104	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTM1—autistic disorder	1.67e-05	0.000104	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PRL—autistic disorder	1.67e-05	0.000104	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—MAPK1—autistic disorder	1.65e-05	0.000102	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TDO2—autistic disorder	1.63e-05	0.000101	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—POMC—autistic disorder	1.62e-05	0.0001	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GPX1—autistic disorder	1.6e-05	9.94e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADRB2—autistic disorder	1.58e-05	9.83e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DHCR7—autistic disorder	1.53e-05	9.48e-05	CbGpPWpGaD
Orlistat—FASN—Disease—HRAS—autistic disorder	1.49e-05	9.27e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AVP—autistic disorder	1.49e-05	9.23e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IGF2—autistic disorder	1.48e-05	9.19e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MTHFR—autistic disorder	1.48e-05	9.17e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HRAS—autistic disorder	1.48e-05	9.17e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC6A8—autistic disorder	1.45e-05	8.98e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—EXT1—autistic disorder	1.45e-05	8.98e-05	CbGpPWpGaD
Orlistat—FASN—Disease—IL6—autistic disorder	1.43e-05	8.87e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL6—autistic disorder	1.42e-05	8.78e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DAO—autistic disorder	1.38e-05	8.57e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOE—autistic disorder	1.38e-05	8.54e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MEF2C—autistic disorder	1.36e-05	8.44e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ITGB3—autistic disorder	1.33e-05	8.23e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—UPB1—autistic disorder	1.33e-05	8.22e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—HRAS—autistic disorder	1.32e-05	8.22e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PIK3CG—autistic disorder	1.24e-05	7.71e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR2A—autistic disorder	1.24e-05	7.68e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL2—autistic disorder	1.24e-05	7.68e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ASMT—autistic disorder	1.23e-05	7.64e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTM5—autistic disorder	1.23e-05	7.64e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—POMC—autistic disorder	1.18e-05	7.34e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TSC2—autistic disorder	1.18e-05	7.3e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC25A12—autistic disorder	1.16e-05	7.18e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LEP—autistic disorder	1.15e-05	7.14e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOE—autistic disorder	1.15e-05	7.14e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC19A1—autistic disorder	1.13e-05	6.99e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PRKCB—autistic disorder	1.09e-05	6.73e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APC—autistic disorder	1.04e-05	6.45e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PIK3CG—autistic disorder	1.04e-05	6.45e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EGF—autistic disorder	1.03e-05	6.37e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ADSL—autistic disorder	1e-05	6.23e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—POMC—autistic disorder	9.89e-06	6.13e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—XDH—autistic disorder	9.85e-06	6.11e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—STX1A—autistic disorder	9.67e-06	5.99e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NPAS2—autistic disorder	9.67e-06	5.99e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IGF1—autistic disorder	9.52e-06	5.9e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—MAPK1—autistic disorder	9.47e-06	5.87e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS2—autistic disorder	9.44e-06	5.85e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TCN2—autistic disorder	9.34e-06	5.79e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SERPINE1—autistic disorder	9.04e-06	5.6e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ADA—autistic disorder	8.91e-06	5.52e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTEN—autistic disorder	8.23e-06	5.1e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—RORA—autistic disorder	8.12e-06	5.04e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MAOB—autistic disorder	7.61e-06	4.72e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HRAS—autistic disorder	7.6e-06	4.72e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL2—autistic disorder	7.31e-06	4.54e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6—autistic disorder	7.28e-06	4.51e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TPH2—autistic disorder	7.07e-06	4.39e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DPYD—autistic disorder	6.96e-06	4.32e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PTEN—autistic disorder	6.88e-06	4.27e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CACNA1C—autistic disorder	6.47e-06	4.01e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DHFR—autistic disorder	5.89e-06	3.65e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAPK1—autistic disorder	5.59e-06	3.47e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP19A1—autistic disorder	4.61e-06	2.86e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HRAS—autistic disorder	4.49e-06	2.79e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6—autistic disorder	4.3e-06	2.67e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—COMT—autistic disorder	4.29e-06	2.66e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTP1—autistic disorder	4.27e-06	2.65e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MAOA—autistic disorder	4.26e-06	2.64e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CAT—autistic disorder	4.15e-06	2.57e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTM1—autistic disorder	3.92e-06	2.43e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLA2G4A—autistic disorder	3.92e-06	2.43e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GPX1—autistic disorder	3.75e-06	2.33e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MTHFR—autistic disorder	3.46e-06	2.15e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOE—autistic disorder	3.23e-06	2e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PIK3CG—autistic disorder	2.91e-06	1.81e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—POMC—autistic disorder	2.77e-06	1.72e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS2—autistic disorder	2.21e-06	1.37e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTEN—autistic disorder	1.93e-06	1.2e-05	CbGpPWpGaD
